|
| Occurrence of both Islet cell and Insulin autoantibodies | Absence of both Islet cell and Insulin autoantibodies | Total | Relative Risk (95% CI) | P-Value |
| Risk Group (Newly Diagnosed Type-1 Diabetics) | 5 | 0 | 5 | 3.75 (2.05 - 3.75) | 0.002 |
| Non-Risk Group (Non-diabetic control) | 40 | 110 | 150 |
|
|
| Total | 45 | 110 | 155 |
|
|